반응식
Br[CH2:2][CH2:3][CH2:4][CH2:5][CH2:6][CH2:7][CH2:8][CH2:9][CH2:10][CH2:11][CH2:12][CH2:13][CH2:14][CH2:15][CH2:16][CH3:17].[CH2:18]1[O:24][P:22]([OH:25])(=[O:23])[CH2:21][O:20][C@H:19]1[CH2:26][N:27]1[C:32](=[O:33])[N:31]=[C:30]([NH2:34])[CH:29]=[CH:28]1>>[CH3:17][CH2:16][CH2:15][CH2:14][CH2:13][CH2:12][CH2:11][CH2:10][CH2:9][CH2:8][CH2:7][CH2:6][CH2:5][CH2:4][CH2:3][CH2:2][O:25][P:22]1([O:24][CH2:18][C@H:19]([CH2:26][N:27]2[C:32](=[O:33])[N:31]=[C:30]([NH2:34])[CH:29]=[CH:28]2)[O:20][CH2:21]1)=[O:23]참가 물질
3
실험 절차
The title compound was prepared using the same procedure as described for Example 1 using 1-bromohexadecane and cyclic cidofovir.
출처 및 근거
- ORD 기록
- ord-1d3188b5b70e4a10971ea3677f6e1210
- 출처 데이터셋
- uspto-grants-2010_01
- 특허 번호
- US07652001B2
연결된 노트
불러오는 중…